Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Halo brings on Modus for strategic review amid multi-million dollar Fonterra deal

  • In News
  • May 8, 2023
  • Alinda Gupta
Halo brings on Modus for strategic review amid multi-million dollar Fonterra deal

A strategic review rarely signals good things. Most times, it reveals the many cracks within the company. But if you’re lucky, the review will end with only great things to say about it. Amid a multi-million dollar deal with dairy nutrition company Fonterra, the functional beverage brand Halo Food Co (ASX: HLF) has decided to onboard Modus Partners to conduct a strategic review. Though it hopes for the latter outcome, shareholders aren’t so confident.

On March 30, 2023, the Company announced that it has engaged the services of Modus Partners, a corporate advisory firm with offices in Sydney and Singapore, to carry out an external strategic evaluation aimed at creating value for all stakeholders and providing recommendations on how to increase shareholder value within the group.  

Halo has launched a strategic review into its 100% owned subsidiary The Healthy Mummy and has subsequently expanded the review to Halo’s entire operations and divisions. As such, Modus is seeking expressions of interest from parties for the Company as a whole or the individual business units of Halo. According to Halo’s board, the review may reveal that its underlying businesses are worth significantly more than their current implied values. 

The review will explore various options, such as divestment, mergers and acquisitions, and partnerships, for individual business units or the Company as a whole, in order to optimise shareholder value.

The Halo Manufacturing unit comprises three standalone production facilities: a powder blending and packing facility, a long-life UHT ready-to-drink PET bottling facility, and a protein bars/healthy snacking and confectionery facility. The business serves a leading customer base in the health and wellness industry. 

On May 1, Halo’s dairy subsidiary Keytone Enterprises (NZ) Company Limited entered into a manufacturing agreement with Fonterra Brands (New Zealand) Limited. Keytone will manufacture nine milk powder products, which will be distributed in several countries, including China, India, Vietnam, and New Zealand. The two-year initial term of the contract is valued at $6 million, and Fonterra has the option to renew it at the end of the term. The finished products will be manufactured at Halo’s New Zealand manufacturing facilities.

In the quarter ending March 31, its New Zealand dairy segment suffered a 22% decline. Both Keytone and The Healthy Mummy underperformed. The total sales for New Zealand were $12.7 million in comparison to $16.3 million for FY22, due to decreased orders from Chinese customers due to high milk powder pricing. THM’s total sales for FY23 were $14 million, compared to $20.1 million for FY22, due to macroeconomic challenges and tighter consumer discretionary spending in e-commerce. To counterbalance this reduction, Halo reduced operating expenses by $160k per month and is exploring additional cost and revenue improvements in the upcoming months.

Besides that, it also reviewed its salaries. The payments made to both executive and non-executive directors continued to decline during Q2 and Q3 of FY23, following the implementation of a salary reduction plan for the board members starting in December 2022. The total reduction was fully implemented during the quarter, resulting in payments of approximately $33,000 for salaries and wages to the directors.

The management has given considerable attention to working capital management during the quarter and plans to continue this focus in FY24. Given that the Company has already implemented solutions, Modus’s role remains a bit vague. Will the strategic review turn out to be an unproblematic move after all?

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx hlf
  • Fonterra
  • halo food
  • hlf
  • keytone
  • the healthy mummy
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.